Comparative Study of Serum Biomarkers BAGE5, RUNX1T1, SLFN14 in Comparison to CA19-9 for the Diagnosis of Pancreatic Cancer: A Comprehensive Review Assessing Their Clinical Application Prospects
-
Published:2024
Issue:03
Volume:14
Page:884-888
-
ISSN:2161-8712
-
Container-title:Advances in Clinical Medicine
-
language:
-
Short-container-title:ACM
Publisher
Hans Publishers
Reference19 articles.
1. 中华人民共和国国家卫生健康委员会医政医管局. 胰腺癌诊疗指南(2022年版) [J]. 中华消化外科杂志, 2022, 21(9): 1117-1136.
2. Roles of CA19-9 in pancreatic cancer: Biomarker, predictor and promoter
3. 梅晗, 周辉, 陈煜枫, 胡燕, 蔚岚, 王小妹. 外周血E-Selectin、P-Selection及K-Ras 基因突变水平在胰腺癌中的表达及意义[J]. 解放军医药杂志, 2021, 33(1): 16-19, 26.
4. BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes
5. New BAGE (B melanoma antigen) genes mapping to the juxtacentromeric regions of human chromosomes 13 and 21 have a cancer/testis expression profile